For those that would like to get a greater understanding of many R&D backend processes and trials and tribulations.
The effect and relationship between ATL-1102 and CD49d and the hurdles that arise and potential pathways to overcome some of these hurdles.
There is clearly a lot of work with testing , results and hypothesis and conjecture to move things forward.
An example is that a product may not achieve efficacy not because it doesnt work, but possibly the mechanism of delivery is restricting it.
There is a lot of insight in this article, if you are curious or bored
I found it another very interesting article when you break it up and look at the different componants and also from different angles and or perspectives.
Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies - PMC (nih.gov)
ps it may take some focus to conceptualise the story.
- Forums
- ASX - By Stock
- Some insights into backend work with ATL-1102
For those that would like to get a greater understanding of many...
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.6¢ |
Change
-0.001(1.30%) |
Mkt cap ! $69.41M |
Open | High | Low | Value | Volume |
7.9¢ | 7.9¢ | 7.6¢ | $15.61K | 200K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 110000 | 7.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 101042 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 110000 | 0.077 |
1 | 49195 | 0.076 |
2 | 113467 | 0.075 |
1 | 200000 | 0.072 |
1 | 20000 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 101042 | 3 |
0.081 | 120000 | 1 |
0.083 | 206000 | 2 |
0.085 | 250000 | 2 |
0.087 | 25001 | 1 |
Last trade - 12.51pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
7.9¢ |
  |
Change
-0.001 ( 1.28 %) |
|||
Open | High | Low | Volume | ||
7.9¢ | 7.9¢ | 7.9¢ | 6979 | ||
Last updated 12.03pm 06/05/2024 ? |
Featured News
PER (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online